Heterogeneous FDG-guided dose-escalation for locally advanced NSCLC (the NARLAL2 trial): Design and early dosimetric results of a randomized, multi-centre phase-III study-Reference-Cited by-同舟云学术

Heterogeneous FDG-guided dose-escalation for locally advanced NSCLC (the NARLAL2 trial): Design and early dosimetric results of a randomized, multi-centre phase-III study

Published:2017-08 Issue:2 Volume:124 Page:311-317
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Møller Ditte Sloth,Nielsen Tine Bjørn,Brink Carsten,Hoffmann Lone,Lutz Christina Maria,Drøgemüller Lund Mikkel,Hansen Olfred,Schytte Tine,Khalil Azza Ahmed,Knap Marianne Marquard,Nyhus Christa Haugaard,Ottosson Wiviann,Sibolt Patrik,Borissova Svetlana,Josipovic Mirjana,Persson Gitte,Appelt Ane Lindegaard

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging,Oncology,Hematology

Reference30 articles.

1. Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer;Auperin;J Clin Oncol,2010

2. Higher biologically effective dose of radiotherapy is associated with improved outcomes for locally advanced non-small cell lung carcinoma treated with chemoradiation: an analysis of the Radiation Therapy Oncology Group;Machtay;Int J Radiat Oncol Biol Phys,2012

3. High-dose radiation improved local tumor control and overall survival in patients with inoperable/unresectable non-small-cell lung cancer: long-term results of a radiation dose-escalation study;Kong;Int J Radiat Oncol Biol Phys,2005

4. Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study

5. Dose heterogeneity in the target volume and intensity-modulated radiotherapy to escalate the dose in the treatment of non-small-cell lung cancer;Schwarz;Int J Radiat Oncol Biol Phys,2005

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Daily CBCT-based dose calculations for enhancing the safety of dose-escalation in lung cancer radiotherapy;Radiotherapy and Oncology;2024-11

2. A planning study of proton therapy dose escalation for non-small cell lung cancer;Physics and Imaging in Radiation Oncology;2024-07

3. A Glimpse Into the Future for Unresectable Stage III Non-Small Cell Lung Cancer;International Journal of Radiation Oncology*Biology*Physics;2023-12

4. A national repository of complete radiotherapy plans: design, Results, and experiences;Acta Oncologica;2023-10-03

5. Outcome of conventional radiotherapy in small centrally located tumours or lymph nodes: minimal toxicity, remarkable survival but challenging loco-regional control;Acta Oncologica;2023-09-14